Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 30/05/19 → 31/12/19 |
Keywords
- Neurological disorders
- Alzheimer's disease
- Clinical trial
A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Doses of AL002 in Healthy Participants and in Participants with Mild to Moderate Alzheimer's Disease.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Brodtmann, Amy (Chief Investigator (CI))
Project: Research